Results 131 to 140 of about 6,424,880 (277)

Proposed alternations to shop at 357 Glenhuntly Rd., Elsternwick : sections, ceiling & roof plans

open access: yes, 1989
Commercial; shop; alternations to existing premisesPhysical format : thick stock paper; 845x600mmIncludes section and planMichael Factor, architect ; Drawn MFScale: 1:1001 ...
Factor, Michael
core  

Primitive ideals and automorphism group of Uq+(B2) [PDF]

open access: yes, 2007
Let g be a complex simple Lie algebra of type B-2 and q be a nonzero complex number which is not a root of unity. In the classical case, a theorem of Dixmier asserts that the simple factor algebras of Gelfand-Kirillov dimension 2 of the positive part U ...
Launois, Stephane
core  

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Alternations to shop at 357 Glenhuntly Rd., Elsternwick

open access: yes, 1989
Commercial; shop; alternations to existing premisesPhysical format : thick stock paper; 845x600mmIncludes plan and elevationsMichael Factor, architectScale: 1 ...
Factor, Michael
core  

The Process $\gamma^*_L$ + $q \to (q \overline q g)$ + q: Real corrections to the virtual photon impact factor

open access: yes, 2002
We calculate, for the longitudinally polarized virtual photon, the cross section of the process \gamma^{*}+q\to (q\bar{q}g)+q at high energies with a large rapidity gap between the fragmentation system q\bar{q}g and the other quark. This process provides
Bartels, Jochen   +2 more
core   +1 more source

Average Nikolskii factors for random trigonometric polynomials

open access: yesJournal of Inequalities and Applications
For 1 ≤ p , q ≤ ∞ $1\le p,q\le \infty $ , the Nikolskii factor for a trigonometric polynomial T a $T_{{\mathbf{a}}}$ is defined by N p , q ( T a ) = ∥ T a ∥ q ∥ T a ∥ p , T a ( x ) = a 1 + ∑ k = 1 n ( a 2 k 2 cos k x + a 2 k + 1 2 sin k x ) .
Yun Ling   +3 more
doaj   +1 more source

Extrapolation theorems for $(p,q)$ -factorable operators

open access: yesBanach Journal of Mathematical Analysis, 2018
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +3 more sources

Comprehensive Characterization of 98 Chinese Cases of Genetic Creutzfeldt‐Jakob Disease With T188K Mutation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li   +11 more
wiley   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy